VFA
TMO icon

Virtus Fund Advisers’s Thermo Fisher Scientific TMO Stock Holding History

Virtus Fund Advisers’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$7.25M Sell
38,180
-857
-2% -$164K 0.07% 208
2017
Q3 		$7.39M Sell
39,037
-4,888
-11% -$885K 0.08% 205
2017
Q2 		$7.8M Buy
43,925
+342
+0.8% +$57.4K 0.08% 215
2017
Q1 		$6.7M Hold
43,583
– – 0.06% 235
2016
Q4 		$6.16M Sell
43,583
-3,180
-7% -$469K 0.05% 232
2016
Q3 		$7.45M Sell
46,763
-968
-2% -$149K 0.07% 217
2016
Q2 		$7.13M Sell
47,731
-1,051
-2% -$155K 0.06% 221
2016
Q1 		$6.91M Hold
48,782
– – 0.06% 232
2015
Q4 		$6.93M Sell
48,782
-977
-2% -$130K 0.06% 223
2015
Q3 		$6.09M Sell
49,759
-18
-0% -$2.35K 0.05% 222
2015
Q2 		$6.46M Buy
49,777
+803
+2% +$105K 0.05% 231
2015
Q1 		$6.58M Sell
48,974
-232
-0.5% -$29.9K 0.05% 230
2014
Q4 		$6.17M Buy
49,206
+5,049
+11% +$614K 0.05% 236
2014
Q3 		$5.37M Buy
44,157
+2,751
+7% +$334K 0.04% 248
2014
Q2 		$4.89M Buy
+41,406
New +$4.87M 0.03% 269

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Virtus Fund Advisers's TMO Position: Q4 2017 in Review

Virtus Fund Advisers reduced its Thermo Fisher Scientific (TMO) stake by 2.2% in Q4 2017, selling an estimated $164K and leaving 38,180 shares worth $7.25M. The position accounts for 0.07% of the portfolio, ranked #208.

Virtus Fund Advisers first reported a position in TMO in Q2 2014 and has held it in 15 quarters since. The position peaked at $7.8M in Q2 2017. 1,246 funds tracked by Wall St. Rank hold TMO as of Q4 2017.

  • Virtus Fund Advisers held 38,180 shares of Thermo Fisher Scientific worth $7.25M as of Q4 2017.
  • Virtus Fund Advisers sold 857 Thermo Fisher Scientific shares in Q4 2017, an estimated $164K.
  • Thermo Fisher Scientific made up 0.07% of Virtus Fund Advisers's portfolio in Q4 2017, its #208 holding.
  • Virtus Fund Advisers first reported a position in Thermo Fisher Scientific in Q2 2014 and has held it in 15 quarters since.
  • Virtus Fund Advisers's Thermo Fisher Scientific position peaked at $7.8M in Q2 2017.
  • 1,246 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.